Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Emrah Okur
Observed names:
EMRAH OKUR,
Okur, Emrah
Institution:
Kütahya Dumlupınar Üniversitesi
Observed institution:
Kütahya Dumlupınar Üniversitesi
ORCID:
0000-0001-5606-7042
Observed ORCID:
0000-0001-5606-7042
OpenAlex ID:
A5087482377
The p53-independent induction of apoptosis in breast cancer cells in response to proteasome inhibitor bortezomib
2012
·
Azmi Yerlikaya
, Emrah Okur
, et al.
·
Tumor Biology
·
66
Differential effects of p38 MAP kinase inhibitors SB203580 and SB202190 on growth and migration of human MDA-MB-231 cancer cell line
2017
·
Şükrü Aydın Düzgün
, Azmi Yerlikaya
, et al.
·
Cytotechnology
·
53
Combined effects of the proteasome inhibitor bortezomib and Hsp70 inhibitors on the B16F10 melanoma cell line
2010
·
Azmi Yerlikaya
, Emrah Okur
, et al.
·
Molecular Medicine Reports
·
40
PDF
A proteomic analysis of p53-independent induction of apoptosis by bortezomib in 4T1 breast cancer cell line
2014
·
Azmi Yerlikaya
, Emrah Okur
, et al.
·
Journal of Proteomics
·
27
A novel combination treatment for breast cancer cells involving BAPTA-AM and proteasome inhibitor bortezomib
2016
·
AZMI YERLIKAYA
, ELIF ERDOĞAN
, et al.
·
Oncology Letters
·
19
PDF
A novel and effective inhibitor combination involving bortezomib and OTSSP167 for breast cancer cells in light of label-free proteomic analysis
2018
·
Emrah Okur
, Azmi Yerlikaya
·
Cell Biology and Toxicology
·
18
An investigation of the mechanisms underlying the proteasome inhibitor bortezomib resistance in PC3 prostate cancer cell line
2019
·
Azmi Yerlikaya
, Emrah Okur
·
Cytotechnology
·
11
PDF
Label-free nLC-MS/MS proteomic analysis reveals significant differences in the proteome between colorectal cancer tissues and normal colon mucosa
2023
·
Sezgin Zeren
, Semih Seker
, et al.
·
Medical Oncology
·
4
Data for a proteomic analysis of p53-independent induction of apoptosis by bortezomib
2014
·
Azmi Yerlikaya
, Emrah Okur
, et al.
·
Data in Brief
·
3
PDF
HRI Kinase Modulation by BTdCPU as a Therapeutic Strategy for Bortezomib Resistance in Prostate Cancer
2026
·
Semih Seker
, Emrah Okur
, et al.
·
Current Medicinal Chemistry
The Effects of 3-(2-Carboxyethyl)phenylboronic Acid and 4-Aminocarbonylphenylboronic Acid Compounds on Parental and Bortezomib-Resistant Prostate Cancer Cell Lines
2026
·
Dulaimi, Nada Ahmed Khalaf
, Yerlikaya, Azmi
, et al.
·
DergiPark (Istanbul University)
PDF
Show more works
View as search
Works count:
11
Citation count:
241
H-index:
7
I10-index:
7
Year
Topic
Type